Lornoxicam

Jump to: navigation, search
Lornoxicam
Lornoxicam skeletal.png
Lornoxicam ball-and-stick.png
Clinical data
AHFS/Drugs.comInternational Drug Names
Pregnancy
category
Routes of
administration
Oral, parenteral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability90–100%
Protein binding99%
MetabolismCYP2C9
Elimination half-life3–4 hours
Excretion2/3 hepatic, 1/3 renal
Identifiers
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC13H10ClN3O4S2
Molar mass371.8192 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)


WikiDoc Resources for Lornoxicam

Articles

Most recent articles on Lornoxicam

Most cited articles on Lornoxicam

Review articles on Lornoxicam

Articles on Lornoxicam in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lornoxicam

Images of Lornoxicam

Photos of Lornoxicam

Podcasts & MP3s on Lornoxicam

Videos on Lornoxicam

Evidence Based Medicine

Cochrane Collaboration on Lornoxicam

Bandolier on Lornoxicam

TRIP on Lornoxicam

Clinical Trials

Ongoing Trials on Lornoxicam at Clinical Trials.gov

Trial results on Lornoxicam

Clinical Trials on Lornoxicam at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lornoxicam

NICE Guidance on Lornoxicam

NHS PRODIGY Guidance

FDA on Lornoxicam

CDC on Lornoxicam

Books

Books on Lornoxicam

News

Lornoxicam in the news

Be alerted to news on Lornoxicam

News trends on Lornoxicam

Commentary

Blogs on Lornoxicam

Definitions

Definitions of Lornoxicam

Patient Resources / Community

Patient resources on Lornoxicam

Discussion groups on Lornoxicam

Patient Handouts on Lornoxicam

Directions to Hospitals Treating Lornoxicam

Risk calculators and risk factors for Lornoxicam

Healthcare Provider Resources

Symptoms of Lornoxicam

Causes & Risk Factors for Lornoxicam

Diagnostic studies for Lornoxicam

Treatment of Lornoxicam

Continuing Medical Education (CME)

CME Programs on Lornoxicam

International

Lornoxicam en Espanol

Lornoxicam en Francais

Business

Lornoxicam in the Marketplace

Patents on Lornoxicam

Experimental / Informatics

List of terms related to Lornoxicam

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lornoxicam (INN, or chlortenoxicam; trade name Xefo, among others) is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic (pain relieving), anti-inflammatory and antipyretic (fever reducing) properties. It is available in oral and parenteral formulations.

Indications

Lornoxicam is used for the treatment of various types of pain, especially resulting from inflammatory diseases of the joints, osteoarthritis, surgery, sciatica, and other inflammations.[1]

Contraindications

The drug is contraindicated in patients that must not take other NSAIDs, possible reasons including salicylate sensitivity, gastrointestinal bleeding and bleeding disorders, and severe impairment of heart, liver or kidney function. Lornoxicam is not recommended during pregnancy and breastfeeding and is contraindicated during the last third of pregnancy.[1]

Adverse effects

Lornoxicam has side effects similar to other NSAIDs, most commonly mild ones like gastrointestinal disorders (nausea and diarrhea) and headache. Severe but seldom side effects include bleeding, bronchospasms and the extremely rare Stevens–Johnson syndrome.[1]

Interactions

Interactions with other drugs are typical of NSAIDs. Combination with vitamin K antagonists like warfarin increases the risk of bleeding. Combination with ciclosporin can lead to reduced kidney function, and to acute renal failure in rare cases. Lornoxicam can also increase the adverse effects of lithium, methotrexate and digoxin and its derivatives. The effect of diuretics, ACE inhibitors and angiotensin II receptor antagonists can be reduced, but this is only relevant in patients with special risks like heart failure. As with piroxicam, cimetidine can increase plasma levels but is unlikely to cause relevant interactions.[2]

References

  1. 1.0 1.1 1.2 Haberfeld, H, ed. (2009). Austria-Codex (in German) (2009/2010 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 3-85200-196-X.
  2. Klopp, T, ed. (2010). Arzneimittel-Interaktionen (in German) (2010/2011 ed.). Arbeitsgemeinschaft für Pharmazeutische Information. ISBN 978-3-85200-207-1.

Linked-in.jpg